FDA Said to Approve Expanded Indication for Janssen's (JNJ) Zytiga
Go back to FDA Said to Approve Expanded Indication for Janssen's (JNJ) Zytiga| Johnson & Johnson (NYSE: JNJ) | Delayed: 251.00 +2.18 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $248.82 | 52 Week High | $126.07 | |||
| Open | $247.45 | 52 Week Low | $94.28 | |||
| Day High | $251.34 | P/E | 52.18 | |||
| Day Low | $245.49 | EPS | $4.81 | |||
| Volume | 1,879,167 | |||||

